221 related articles for article (PubMed ID: 32426332)
1. Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma.
Wang Y; He R; Ma L
Front Bioeng Biotechnol; 2020; 8():266. PubMed ID: 32426332
[TBL] [Abstract][Full Text] [Related]
2. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
Hu J; Wang T; Chen Q
Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
6. Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.
Cui Y; Cui Y; Gu R; Liu Y; Wang X; Bi L; Zhang S; Fan W; Tian F; Zhan Y; Zhang N; Xing Y; Cai L
J Oncol; 2021; 2021():2659550. PubMed ID: 34987577
[TBL] [Abstract][Full Text] [Related]
7. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
Front Genet; 2020; 11():625977. PubMed ID: 33584817
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
Wu X; Sui Z; Zhang H; Wang Y; Yu Z
Front Oncol; 2020; 10():554759. PubMed ID: 33042838
[TBL] [Abstract][Full Text] [Related]
9. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Li X; Li B; Ran P; Wang L
Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
Liu N; Liu Z; Liu X; Chen H
Front Oncol; 2019; 9():935. PubMed ID: 31649871
[TBL] [Abstract][Full Text] [Related]
11. A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma.
Wang WJ; Li HT; Yu JP; Han XP; Xu ZP; Li YM; Jiao ZY; Liu HB
J Surg Res; 2019 Mar; 235():22-33. PubMed ID: 30691798
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis.
Han P; Yang H; Li X; Wu J; Wang P; Liu D; Xiao G; Sun X; Ren H
Oncol Res; 2021 Sep; 28(7):715-729. PubMed ID: 33106209
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nomogram Based on Circular RNA-Associated Competing Endogenous RNA Network for Patients with Lung Adenocarcinoma.
Li Y; Sun R; Li R; Chen Y; Du H
Oxid Med Cell Longev; 2021; 2021():9978206. PubMed ID: 34497684
[TBL] [Abstract][Full Text] [Related]
15. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
Wu X; Liu J; Zhu C; Ma M; Chen X; Liu Y; Xia N; Dong Q
Med Sci Monit; 2020 Dec; 26():e927725. PubMed ID: 33328429
[TBL] [Abstract][Full Text] [Related]
16. Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease.
Zhang X; Feng S; Fan Y; Luo Y; Jin L; Li S
Front Neurol; 2020; 11():810. PubMed ID: 32849243
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Prognostic Signature Composed of GPI, IL22RA1, CCT6A and SPOCK1 for Lung Adenocarcinoma Based on Bioinformatic Analysis of lncRNA-Mediated ceRNA Network and Sample Validation.
Tang W; Lu Q; Zhu J; Zheng X; Fang N; Ji S; Lu F
Front Oncol; 2022; 12():844691. PubMed ID: 35433415
[TBL] [Abstract][Full Text] [Related]
18. Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Pan Y; Liu G; Wang D; Li Y
Front Pharmacol; 2019; 10():150. PubMed ID: 30886579
[TBL] [Abstract][Full Text] [Related]
19. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
[TBL] [Abstract][Full Text] [Related]
20. Screening key prognostic factors and constructing survival prognostic risk prediction model based on ceRNA network in early lung adenocarcinoma.
Bai J; Zhu X; Zhang J; Bulin B
Transl Cancer Res; 2021 Nov; 10(11):4652-4663. PubMed ID: 35116321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
